Virus News and Research

Latest Virus News and Research

Idera second quarter net loss increases to $6.3 million

Idera second quarter net loss increases to $6.3 million

Scientists identify small molecule inhibitors of cellular uptake

Scientists identify small molecule inhibitors of cellular uptake

Triple threat of catching three varieties of flu in one season

Triple threat of catching three varieties of flu in one season

New HIV numbers stable at 50,000 per year, down from 130,000 in the mid-1980s

New HIV numbers stable at 50,000 per year, down from 130,000 in the mid-1980s

Akonni to develop closed amplicon RT-PCR microarray for virus detection in CSF

Akonni to develop closed amplicon RT-PCR microarray for virus detection in CSF

CDC: HIV infection rates hold steady except among young black males

CDC: HIV infection rates hold steady except among young black males

Novel DNA sensing pathway linked to increased susceptibility to malaria

Novel DNA sensing pathway linked to increased susceptibility to malaria

World must scale up AIDS fight, even as donors scale back

World must scale up AIDS fight, even as donors scale back

Tips to minimize risk of bug bites and related illnesses

Tips to minimize risk of bug bites and related illnesses

Gold nanoparticles for rapid, accurate diagnosis of flu

Gold nanoparticles for rapid, accurate diagnosis of flu

USDA NIFA awards NC State $25M grant to study human noroviruses

USDA NIFA awards NC State $25M grant to study human noroviruses

Concentrated HIV epidemics emerging among MSM in Middle East, North Africa, study shows

Concentrated HIV epidemics emerging among MSM in Middle East, North Africa, study shows

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

Viewpoints: Geithner, Bowles, Simpson, Ryan, Vladeck, Wilensky on health spending and the deficit

Viewpoints: Geithner, Bowles, Simpson, Ryan, Vladeck, Wilensky on health spending and the deficit

NanoViricides to apply 'lead optimization technology' to anti-HIV candidate

NanoViricides to apply 'lead optimization technology' to anti-HIV candidate

Study looks at HIV infections in Middle East and North Africa

Study looks at HIV infections in Middle East and North Africa

Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma

Positive results from Jennerex JX-594 proof-of-concept trial on metastatic melanoma

Alnylam second quarter revenue decreases to $20.6 million

Alnylam second quarter revenue decreases to $20.6 million

New birth control guidelines in U.S.

New birth control guidelines in U.S.

Preventive health services at no additional cost for women: HHS

Preventive health services at no additional cost for women: HHS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.